Metoclopramide News and Research

RSS
Severe vomiting in early pregnancy linked to increased autism risk

Severe vomiting in early pregnancy linked to increased autism risk

MII-pH can help doctors confirm diagnosis of GERD in newborns before treatment

MII-pH can help doctors confirm diagnosis of GERD in newborns before treatment

Pregnant women with acute migraine more likely to experience adverse birth outcomes

Pregnant women with acute migraine more likely to experience adverse birth outcomes

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

FDA approves RYTARY for Parkinson's disease treatment

FDA approves RYTARY for Parkinson's disease treatment

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Parkinson’s patients encouraged to order new Parkinson’s Passport to avoid medicine problems

Parkinson’s patients encouraged to order new Parkinson’s Passport to avoid medicine problems

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

New endoscopic technique reduces symptoms in gastroparesis patients

New endoscopic technique reduces symptoms in gastroparesis patients

BD receives FDA approval for second prefilled injectable drug

BD receives FDA approval for second prefilled injectable drug

FDA accepts Merck's NDA for NOXAFIL tablets

FDA accepts Merck's NDA for NOXAFIL tablets

FTC votes to approve Watson's acquisition of Actavis

FTC votes to approve Watson's acquisition of Actavis

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

No legal recourse because generic drug caused injury

No legal recourse because generic drug caused injury

Positive results from Acacia Phase II APD421 study in prevention of post-operative nausea & vomiting

Positive results from Acacia Phase II APD421 study in prevention of post-operative nausea & vomiting

Salix first quarter total product revenue increases 62% to $171.1M

Salix first quarter total product revenue increases 62% to $171.1M

Greater patient and healthcare provider dialogue needed for morning sickness

Greater patient and healthcare provider dialogue needed for morning sickness